bioRxivMolecular BiologyPreprint
Latrophilin-2 mediates flow activation of Notch to control vascular endothelial phenotype and atherosclerosis
Keiichiro TanakaiD, Minghao CheniD, Divyesh JoshiiD, Manasa V.L. ChanduriiD, Hanming ZhangiD, Carlos F Fernandez-HernandoiD, Yoo-Min KohiD, Martin Alexander SchwartziD
- Citations
- 0
Abstract
Fluid shear stress (FSS) is a major determinant of endothelial cell (EC) phenotype, with physio-logical laminar FSS promoting arterial identity and stability, and disturbed FSS promoting atherosclerosis. We previously identified the adhesion G protein-coupled receptor (GPCR) Latrophilin-2 (LPHN2) as a junctional protein required for FSS activation of the PECAM1/VE-cadherin/VEGFR2/PlexinD1 junctional mechanosensory pathway, which regulates EC alignment to laminar blood flow and promotes EC inflammatory activation and atherogenesis under disturbed flow. Here, we demonstrate that Lphn2 endothelial cell-specific knockout hyperlipidemic mice develop larger atherosclerotic plaques than controls--opposite from the previously reported Pecam1 knockout model. Transcriptomic analysis revealed that LPHN2 contributes more than half of flow-responsive gene expression and suppresses pro-inflammatory pathways. Critically, LPHN2 is essential for FSS-induced Notch1 activation to suppress inflammation, via a GPCR-independent mechanism. Active Notch correlates with physical association of LPHN2 with Notch1 activator, {gamma}-secretase, and Notch1 in response to flow. Both the Notch1 intracellular domain (NICD) and transmembrane domain (NTMD) contribute to the anti-inflammatory gene program, with the non-canonical NTMD signaling specifically suppressing the pro-inflammatory YAP pathway. Together with the accompanying paper showing that LPHN2 also mediates flow activation of the Smad1/5 pathway, these data identify LPHN2 as a central mediator of EC flow responses through multiple independent mechanisms in vascular biology and disease.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Latrophilin-2 mediates fluid shear stress mechanotransduction at endothelial junctions
Keiichiro Tanaka, Minghao Chen, … Martin Alexander Schwartz·The EMBO JournalPeer-reviewed·Jun 17, 2024
- Latrophilin-2 Orchestrates Endothelial Flow-Mediated Smad1/5 Activation via Endoglin and Shank3
Keiichiro Tanaka, Manasa V.L. Chanduri, … Martin Alexander Schwartz·bioRxiv·Jun 30, 2025
- LPHN2 inhibits vascular permeability by differential control of endothelial cell adhesion
C. Camillo, N. Facchinello, … G. Serini·bioRxiv·Apr 28, 2020
- Mechanosensitive FHL2 tunes endothelial function
Shailaja Seetharaman, John Michael Devany, … Margaret L. Gardel·The EMBO JournalPeer-reviewed·May 26, 2026
- FAK activity exacerbates disturbed flow-mediated atherosclerosis via VEGFR2-Cbl-NF-κB signaling.
James M. Murphy, Duyen Thi Kieu Tran, … Ssang‐Taek Lim·Journal of Biological ChemistryPeer-reviewed·Jun 14, 2025
- JAG1-NOTCH4 MECHANOSENSING DRIVES ATHEROSCLEROSIS
C. Souilhol, X. Li, … P. Evans·bioRxiv·May 15, 2020